Teerat Sawangpanyangkura, Panwadee Bandhaya, Pattanin Montreekachon, Anongwee Leewananthawet, Arintaya Phrommintikul, Nipon Chattipakorn, & Siriporn C. Chattipakorn. (2022). The elevation of fibroblast growth factor 21 is associated with generalized periodontitis in patients with treated metabolic syndrome. BMC.
Παραπομπή σε μορφή Chicago (17η εκδ.)Teerat Sawangpanyangkura, Panwadee Bandhaya, Pattanin Montreekachon, Anongwee Leewananthawet, Arintaya Phrommintikul, Nipon Chattipakorn, και Siriporn C. Chattipakorn. The Elevation of Fibroblast Growth Factor 21 Is Associated with Generalized Periodontitis in Patients with Treated Metabolic Syndrome. BMC, 2022.
Παραπομπή σε μορφή MLA (9th εκδ.)Teerat Sawangpanyangkura, et al. The Elevation of Fibroblast Growth Factor 21 Is Associated with Generalized Periodontitis in Patients with Treated Metabolic Syndrome. BMC, 2022.